Intelligent Medicine Acquisition Corp.

Intelligent Medicine Acquisition Corp. (Nasdaq: IQMD) is a blank-check company that completed its initial public offering in 2021, targeting acquisition opportunities in the healthcare and life sciences sector. The company filed a Form 10-Q with the Securities and Exchange Commission on November 14, 2022, under accession number 0001104659-22-118572, reflecting its operational status as a special purpose acquisition company during its search for a qualifying business combination. IQMD's stated focus centers on companies at the intersection of medicine, technology, and innovation. To access complete filing history, deal timelines, and real-time SPAC analytics on IQMD and the broader SPAC universe, sign up for full data on SpacDesk.